Table 1. Clinicopathological characteristics and DEPTOR expression in patients with ESCC.
Characteristic | DEPTOR | |||
---|---|---|---|---|
Negative | Positive | X2 | p value | |
Age | 0.105 | 0.746 | ||
≤ 53 | 19 | 12 | ||
≥ 53 | 16 | 12 | ||
Gender | 0.034 | 0.854 | ||
Male | 27 | 19 | ||
Female | 8 | 5 | ||
Tumor size | 1.787 | 0.409 | ||
≤ 3 cm | 7 | 6 | ||
3–5 cm | 15 | 13 | ||
> 5 cm | 13 | 5 | ||
Tumor location | 0.185# | 1.000 | ||
Upper | 5 | 3 | ||
Middle | 14 | 9 | ||
lower | 16 | 12 | ||
TNM stage | 8.866 | 0.003* | ||
I–II | 11 | 17 | ||
III–IV | 24 | 7 | ||
Lymph node metastasis | 6.602 | 0.010* | ||
Yes | 19 | 5 | ||
No | 16 | 19 | ||
Differentiationa | 0.125# | 1.000 | ||
Well | 6 | 4 | ||
Moderate | 21 | 15 | ||
poor | 8 | 5 |
ESCC cases (n = 59) were categorized as DEPTOR-positive (n = 24) and DEPTOR-negative (n = 35). χ test was used to test the difference expression of DEPTOR.
If cells have expected count less than 5, Fisher's Exact test was used.
p < 0.05.
Well, well differenciated squamous cell carcinoma; Moderate, moderately differenciated squamous cell carcinoma; poor, poorly differenciated squamous cell carcinoma.